These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 205637)

  • 41. [The significance of notches or bites in the vectorcardiogram. Study in cardiopathy caused by adriamycin].
    Vitolo E; Madoi S; Roveda M; Larovere MT; Beretta G; Obbiassi M
    Boll Soc Ital Cardiol; 1980; 25(9):1073-5. PubMed ID: 7284195
    [No Abstract]   [Full Text] [Related]  

  • 42. [Serial echocardiographic evaluation of subjects treated with adriamycin].
    Messina L; Palmieri S; Bonnì G; D'Alessandro N; Rausa L; Raineri A
    Boll Soc Ital Cardiol; 1981; 26(12):2231-7. PubMed ID: 7185392
    [No Abstract]   [Full Text] [Related]  

  • 43. Uptake of Tc-99m pyrophosphate by the lactating breast.
    Landgarten S
    J Nucl Med; 1977 Sep; 18(9):943. PubMed ID: 197135
    [No Abstract]   [Full Text] [Related]  

  • 44. [Proposals for the preparation and testing of radiopharmac critical agents. Proposal for the preparation and testing of 99m Tc-Sn pyrophosphate for bone scintigraphy].
    Charamza O
    Cesk Farm; 1974 Sep; 23(7):290. PubMed ID: 4373179
    [No Abstract]   [Full Text] [Related]  

  • 45. Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?
    Jain D; Zaret BL
    J Nucl Med; 1990 Dec; 31(12):1970-4. PubMed ID: 2266395
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparison of technetium etidronate and pyrophosphate for acute myocardial infarct imaging.
    Williams CC; Nishiyama H; Adolph RJ; Romhilt DW; Sodd VJ; Saenger EL; Gabel M
    J Nucl Med; 1977 Sep; 18(9):905-9. PubMed ID: 197134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlations of Tc-99m pyrophosphate myocardial scintigraphy and the results of coronary-artery bypass surgery.
    Lyons KP; Olson HG; Kuperus J; Stemmer EA; Aronow WS
    J Nucl Med; 1978 Oct; 19(10):1116-20. PubMed ID: 214526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative evaluation of separate and combined use of strontium-85 and technetium-99m pyrophosphate for diagnosis of bone tumors].
    Mechev DM; Knysh IT; Shishkina VV; Korolev VI
    Ortop Travmatol Protez; 1980 Dec; (12):11-6. PubMed ID: 6261201
    [No Abstract]   [Full Text] [Related]  

  • 49. The specificity of pyrophosphate myocardial scintigrams in patients with prior myocardial infarction: concise communication.
    Botvinick EH; Shames DM; Sharpe DN; Klausner SC; Werner JA; Chatterjee K; Parmley WW
    J Nucl Med; 1978 Oct; 19(10):1121-5. PubMed ID: 214527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormal myocardial image with 99mTc-pyrophosphate in a child on chemotherapy.
    Sty JR; Garrett R
    Clin Nucl Med; 1978 Feb; 3(2):65-6. PubMed ID: 657657
    [No Abstract]   [Full Text] [Related]  

  • 51. Adriamycin cardiomyopathy: enhanced cardiac damage in rabbits with combined drug and cardiac irradiation.
    Eltringham JR; Fajardo LF; Stewart JR
    Radiology; 1975 May; 115(2):471-2. PubMed ID: 806934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [99mTc-pyrophosphate myocardial scintigraphy in patients with chronic stable angina pectoris (author's transl)].
    Aldor E; Heeger H; Kahn P
    Rofo; 1981 Feb; 134(2):192-5. PubMed ID: 6260607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cardiac risks of adriamycin. Early detection of high-risk patients by isotopic cardiac function study].
    Pecking A; Delorme G; Berlie J; Goupil A; Tubiana M; Turpin F; Meeus L; Clavel B
    Presse Med; 1983 Nov; 12(39):2445-8. PubMed ID: 6227889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localization of Tc-99m-pyrophosphate in the liver due to massive liver necrosis: case report.
    Lyons KP; Kuperus J; Green HW
    J Nucl Med; 1977 Jun; 18(6):550-2. PubMed ID: 192858
    [No Abstract]   [Full Text] [Related]  

  • 56. Use of blood-pool imaging in evaluation of diffuse activity patterns in technetium-99m pyrophosphate myocardial scintigraphy.
    Cowley MJ; Mantle JA; Rogers WJ; Russell RO; Rackley CE; Logic JR
    J Nucl Med; 1979 Jun; 20(6):496-501. PubMed ID: 231644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anthracyclines and the heart.
    Thomas P
    Br Heart J; 1994 Sep; 72(3):300. PubMed ID: 7946789
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.
    Adamson RH
    Cancer Chemother Rep; 1974; 58(3):293-4. PubMed ID: 4841712
    [No Abstract]   [Full Text] [Related]  

  • 59. [Application of nuclear medicine to the diagnosis of myocardial infarct].
    Ando J; Yasuda H; Miyamoto A; Kobayashi T
    Nihon Rinsho; 1980 Oct; 38(10):4023-32. PubMed ID: 6265661
    [No Abstract]   [Full Text] [Related]  

  • 60. Detection of acute endothelial injury with intravenous radionuclide.
    Greenstein BD; Rudavsky AZ; Veith FJ; Moss CM
    Surg Forum; 1978; 29():476-8. PubMed ID: 233837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.